Suppr超能文献

原发性高血压患者血清salusin-α水平降低,且与颈动脉粥样硬化呈负相关。

Serum salusin-alpha levels are decreased and correlated negatively with carotid atherosclerosis in essential hypertensive patients.

作者信息

Watanabe Takuya, Suguro Toshiaki, Sato Kengo, Koyama Takatoshi, Nagashima Masaharu, Kodate Syuusuke, Hirano Tsutomu, Adachi Mitsuru, Shichiri Masayoshi, Miyazaki Akira

机构信息

Department of Biochemistry, Showa University School of Medicine, Tokyo, Japan.

出版信息

Hypertens Res. 2008 Mar;31(3):463-8. doi: 10.1291/hypres.31.463.

Abstract

Salusin-alpha is a new bioactive peptide with mild hypotensive and bradycardic effects. Our recent study showed that salusin-alpha suppresses foam cell formation in human monocyte-derived macrophages by down-regulating acyl-CoA:cholesterol acyltransferase-1, contributing to its anti-atherosclerotic effect. To clarify the clinical implications of salusin-alpha in hypertension and its complications, we examined the relationship between serum salusin-alpha levels and carotid atherosclerosis in hypertensive patients. The intima-media thickness (IMT) and plaque score in the carotid artery, blood pressure, serum levels of salusin-alpha, and atherosclerotic parameters were determined in 70 patients with essential hypertension and in 20 normotensive controls. There were no significant differences in age, gender, body mass index, fasting plasma glucose level, or serum levels of high-sensitive C-reactive protein, high- or low-density lipoprotein (LDL) cholesterol, small dense LDL, triglycerides, lipoprotein(a), or insulin between the two groups. Serum salusin-alpha levels were significantly lower in hypertensive patients than in normotensive controls. The plasma urotensin-II level, maximal IMT, plaque score, systolic and diastolic blood pressure, and homeostasis model assessment for insulin resistance (HOMA-IR) were significantly greater in hypertensive patients than in normotensive controls. In all subjects, maximal IMT was significantly correlated with age, systolic blood pressure, LDL cholesterol, urotensin-II, salusin-alpha, and HOMA-IR. Forward stepwise multiple linear regression analysis revealed that salusin-alpha levels had a significantly independent and negative association with maximal IMT. Serum salusin-alpha levels were significantly lower in accordance with the severity of plaque score. Our results suggest that the decrease in serum salusin-alpha, an anti-atherogenic peptide, may be associated with carotid atherosclerosis in hypertensive patients.

摘要

Salusin-α是一种具有轻度降压和减慢心率作用的新型生物活性肽。我们最近的研究表明,Salusin-α通过下调酰基辅酶A:胆固醇酰基转移酶-1抑制人单核细胞衍生巨噬细胞中泡沫细胞的形成,这有助于其抗动脉粥样硬化作用。为了阐明Salusin-α在高血压及其并发症中的临床意义,我们研究了高血压患者血清Salusin-α水平与颈动脉粥样硬化之间的关系。测定了70例原发性高血压患者和20例血压正常对照者的颈动脉内膜中层厚度(IMT)和斑块评分、血压、Salusin-α血清水平以及动脉粥样硬化参数。两组在年龄、性别、体重指数、空腹血糖水平、高敏C反应蛋白、高密度或低密度脂蛋白(LDL)胆固醇、小而密LDL、甘油三酯、脂蛋白(a)或胰岛素的血清水平方面无显著差异。高血压患者的血清Salusin-α水平显著低于血压正常对照者。高血压患者的血浆尾加压素II水平、最大IMT、斑块评分、收缩压和舒张压以及胰岛素抵抗的稳态模型评估(HOMA-IR)均显著高于血压正常对照者。在所有受试者中,最大IMT与年龄、收缩压、LDL胆固醇、尾加压素II、Salusin-α和HOMA-IR显著相关。向前逐步多元线性回归分析显示,Salusin-α水平与最大IMT具有显著独立的负相关。血清Salusin-α水平根据斑块评分的严重程度显著降低。我们的结果表明,抗动脉粥样硬化肽血清Salusin-α的降低可能与高血压患者的颈动脉粥样硬化有关。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验